Nutritional Considerations in Joint Health

Clinics in Sports Medicine

Volumn 26, Issue 1, 2007, Pages 101-118

  Clark, Kristine L ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ASCORBIC ACID DERIVATIVE; CALCIUM; CALCIUM ASCORBATE; CELECOXIB; CHONDROITIN SULFATE; COLLAGEN; CYCLOOXYGENASE 2 INHIBITOR; DIMETHYL SULFONE; FOOD ADDITIVE; GLUCOCORTICOID; GLUCOSAMINE SULFATE; GREEN TEA EXTRACT; HARPAGOPHYTUM PROCUMBEN EXTRACT; HERBACEOUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHOSPHORUS; PLANT EXTRACT; PROTEIN; ROFECOXIB; S ADENOSYLMETHIONINE; SKI 306X; TRIPTERYGIUM WILFORDII EXTRACT; UNCLASSIFIED DRUG; VITAMIN D; ZINC;

AEROBIC EXERCISE; AGING; ANALGESIA; ARTHRALGIA; ARTHROPATHY; ARTICULAR CARTILAGE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE STRENGTH; BONE STRESS; CARDIOVASCULAR RISK; CHEMICAL COMPOSITION; CHINESE HERB; COLLAGEN SYNTHESIS; CONGENITAL MALFORMATION; DEGENERATIVE DISEASE; DIETARY INTAKE; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DUODENUM ULCER; EPIGASTRIC DISCOMFORT; EXERCISE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HERBAL MEDICINE; HUMAN; ISOKINETIC EXERCISE; ISOMETRIC EXERCISE; ISOTONIC EXERCISE; JOINT; JOINT DEGENERATION; JOINT FUNCTION; JOINT INJURY; KNEE OSTEOARTHRITIS; LIFESTYLE; MUSCLE STRETCHING; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL REQUIREMENT; OBESITY; OSTEOARTHRITIS; PAIN ASSESSMENT; PHYSICAL STRESS; RANGE OF MOTION; REPETITIVE STRAIN INJURY; REVIEW; RHEUMATOID ARTHRITIS; SHEAR STRESS; SHORT FORM 36; SIDE EFFECT; SPORTS MEDICINE; STOMACH ULCER; SYNOVIAL FLUID; TREATMENT OUTCOME; WEIGHT REDUCTION;

CARTILAGE, ARTICULAR; CLINICAL TRIALS; DIETARY SUPPLEMENTS; EXERCISE; HUMANS; JOINT DISEASES; JOINTS; NUTRITIONAL REQUIREMENTS; PHYTOTHERAPY;

EID: 33846260281     PISSN: 02785919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csm.2006.11.006     Document Type: Review

References (89)

1. Clegg D.O., Reda D.J., Harris C.L., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354 (2006) 795-808
2. United States Senate Committee on Health E, Labor and Pensions, Subcommittee on Aging. Centers for Disease Control's role in combating the burden of arthritis (2004), Department of Health and Human Services, Washington, DC
3. In: Cotran R.S., Kumar V., and Collins T. (Eds). Pathologic basis of disease. 6th edition (1999), Saunders, Philadelphia
4. Resnick D. Common disorders of synovium-lined joints: pathogenesis, imaging abnormalities, and complications. AJR Am J Roentgenol 151 (1988) 1079-1093
5. Young A.A., Smith M.M., Smith S.M., et al. Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis. Arthritis Res Ther 7 (2005) R852-R861
6. Brandt K.D. Osteoarthritis. In: Braunwald E., Fauci A.S., Kasper D.L., et al. (Eds). Harrison's principles of internal medicine. 15th edition (2001), McGraw-Hill, New York 1987-1994
7. Rosier R.N., and O'Keefe R.J. Autocrine regulation of articular cartilage. Instr Course Lect 47 (1998) 469-475
8. Baker Jr. C.L., and Ferguson C.M. Future treatment of osteoarthritis. Orthopedics 28 2 Suppl (2005) s227-s234
9. Trippel S.B. Growth factor actions on articular cartilage. J Rheumatol 43 Suppl (1995) 129-132
10. Poole A.R. Cartilage in health and disease. In: McCarty D.J., and Koopman W.J. (Eds). Arthritis and allied conditions: a textbook of rheumatology (1993), Lea & Febiger, Philadelphia 279-333
11. Rizzo R., Grandolfo M., Godeas C., et al. Calcium, sulfur, and zinc distribution in normal and arthritic articular equine cartilage: a synchrotron radiation-induced X-ray emission (SRIXE) study. J Exp Zool 273 (1995) 82-86
12. Clark A.G., Rohrbaugh A.L., Otterness I., et al. The effects of ascorbic acid on cartilage metabolism in guinea pig articular cartilage explants. Matrix Biol 21 (2002) 175-184
13. Wang Y., Prentice L.F., Vitetta L., et al. The effect of nutritional supplements on osteoarthritis. Altern Med Rev 9 (2004) 275-296
14. Gerstenfeld L.C., Kelly C.M., Von Deck M., et al. Effect of 1,25-dihydroxyvitamin D3 on induction of chondrocyte maturation in culture: extracellular matrix gene expression and morphology. Endocrinology 126 (1990) 1599-1609
15. White-O'Connor B., and Sobal J. Nutrient intake and obesity in a multidisciplinary assessment of osteoarthritis. Clin Ther 9 Suppl B (1986) 30-42
16. McAlindon T.E., Felson D.T., Zhang Y., et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham study. Ann Intern Med 125 (1996) 353-359
17. Tiku M.L., Shah R., and Allison G.T. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation: possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem 275 (2000) 20069-20076
18. Kaiki G., Tsuji H., Yonezawa T., et al. Osteoarthrosis induced by intra-articular hydrogen peroxide injection and running load. J Orthop Res 8 (1990) 731-740
19. Kowsari B., Finnie S.K., Carter R.L., et al. Assessment of the diet of patients with rheumatoid arthritis and osteoarthritis. J Am Diet Assoc 82 (1983) 657-659
20. Grennan D.M., Knudson J.M., Dunckley J., et al. Serum copper and zinc in rheumatoid arthritis and osteoarthritis. N Z Med J 91 (1980) 47-50
21. Meachin G., and Brooks G. The pathology of osteoarthritis. In: Moskowitz R.W., Howell D.S., Goldberg V.M., et al. (Eds). Osteoarthritis: diagnosis and management (1984), Saunders, Philadelphia 29-42
22. Howell D.S. Pathogenesis of osteoarthritis. Am J Med 80 4B (1986) 24-28
23. Adams M.E. Pathogenesis of osteoarthritis. In: Hadler N.M. (Ed). Clinical concepts in regional musculoskeletal illness (1987), Grune & Stratton, Orlando (FL) 137-167
24. Hamerman D. The biology of osteoarthritis. N Engl J Med 320 (1989) 1322-1330
25. Spector T.D. The fat on the joint: osteoarthritis and obesity. J Rheumatol 17 (1990) 283-284
26. Felson D.T., Anderson J.J., Naimark A., et al. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med 109 (1988) 18-24
27. Coggon D., Reading I., Croft P., et al. Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord 25 (2001) 622-627
28. Carman W.J., Sowers M., Hawthorne V.M., et al. Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. Am J Epidemiol 139 (1994) 119-129
29. Cicuttini F.M., Baker J.R., and Spector T.D. The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 23 (1996) 1221-1226
30. Haara M.M., Manninen P., Kroger H., et al. Osteoarthritis of finger joints in Finns aged 30 or over: prevalence, determinants, and association with mortality. Ann Rheum Dis 62 (2003) 151-158
31. Wilhelmi G. [Potential influence of nutrition with supplements on healthy and arthritic joints. II. Nutritional quantity, supplements, contamination]. Z Rheumatol 52 (1993) 191-200
32. Exercise prescription for older adults with osteoarthritis pain: consensus practice recommendations. A supplement to the AGS Clinical Practice Guidelines on the management of chronic pain in older adults. J Am Geriatr Soc 49 (2001) 808-823
33. O'Reilly S.C., Muir K.R., and Doherty M. Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial. Ann Rheum Dis 58 (1999) 15-19
34. Marks R. The effect of isometric quadriceps strength training in mid-range for osteoarthritis of the knee. Arthritis Care Res 6 (1993) 52-56
35. Fisher N.M., Pendergast D.R., Gresham G.E., et al. Muscle rehabilitation: its effect on muscular and functional performance of patients with knee osteoarthritis. Arch Phys Med Rehabil 72 (1991) 367-374
36. Deyle G.D., Henderson N.E., Matekel R.L., et al. Effectiveness of manual physical therapy and exercise in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med 132 (2000) 173-181
37. Thomas K.S., Muir K.R., Doherty M., et al. Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ 325 (2002) 752
38. Schwartz E.R., Leveille C.R., Stevens J.W., et al. Proteoglycan structure and metabolism in normal and osteoarthritic cartilage of guinea pigs. Arthritis Rheum 24 (1981) 1528-1539
39. Schwartz E.R., Oh W.H., and Leveille C.R. Experimentally induced osteoarthritis in guinea pigs: metabolic responses in articular cartilage to developing pathology. Arthritis Rheum 24 (1981) 1345-1355
40. McAlindon T.E., Jacques P., Zhang Y., et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?. Arthritis Rheum 39 (1996) 648-656
41. Jensen N.H. [Reduced pain from osteoarthritis in hip joint or knee joint during treatment with calcium ascorbate: a randomized, placebo-controlled cross-over trial in general practice]. Ugeskr Laeger 165 (2003) 2563-2566
42. Blankenhorn G. [Clinical effectiveness of Spondyvit (vitamin E) in activated arthroses: a multicenter placebo-controlled double-blind study]. Z Orthop Ihre Grenzgeb 124 (1986) 340-343
43. Machtey I., and Ouaknine L. Tocopherol in osteoarthritis: a controlled pilot study. J Am Geriatr Soc 26 (1978) 328-330
44. Scherak O., Kolarz G., Schodl C., et al. [High dosage vitamin E therapy in patients with activated arthrosis]. Z Rheumatol 49 (1990) 369-373
45. Brand C., Snaddon J., Bailey M., et al. Vitamin E is ineffective for symptomatic relief of knee osteoarthritis: a six month double blind, randomised, placebo controlled study. Ann Rheum Dis 60 (2001) 946-949
46. Wluka A.E., Stuckey S., Brand C., et al. Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: a 2 year double blind randomized placebo controlled study. J Rheumatol 29 (2002) 2585-2591
47. Dougados M. Why and how to use NSAIDs in osteoarthritis. J Cardiovasc Pharmacol 47 Suppl 1 (2006) S49-S54
48. Brandt K.D. Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis?. Rheum Dis Clin N Am 19 (1993) 29-44
49. Mitchell J.A., Akarasereenont P., Thiemermann C., et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 90 (1993) 11693-11697
50. Silverstein F.E., Faich G., Goldstein J.L., et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284 (2000) 1247-1255
51. Bombardier C., Laine L., Reicin A., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343 (2000) 1520-1528
52. Levesque L.E., Brophy J.M., and Zhang B. Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors. Can Med Assoc J 174 (2006) 1563-1569
53. Towheed T.E., and Hochberg M.C. A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology. Semin Arthritis Rheum 26 (1997) 755-770
54. Raynauld J.P., Buckland-Wright C., Ward R., et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 48 (2003) 370-377
55. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 43 (2000) 1905-1915
56. Pendleton A., Arden N., Dougados M., et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 59 (2000) 936-944
57. Gossec L., and Dougados M. Intra-articular treatments in osteoarthritis: from the symptomatic to the structure modifying. Ann Rheum Dis 63 (2004) 478-482
58. Curtis C.L., Harwood J.L., Dent C.M., et al. Biological basis for the benefit of nutraceutical supplementation in arthritis. Drug Discov Today 9 (2004) 165-172
59. Haqqi T.M., Anthony D.D., Gupta S., et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A 96 (1999) 4524-4529
60. Adcocks C., Collin P., and Buttle D.J. Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage proteoglycan and type II collagen degradation in vitro. J Nutr 132 (2002) 341-346
61. Singh R., Ahmed S., Islam N., et al. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum 46 (2002) 2079-2086
62. Tao X., Younger J., Fan F.Z., et al. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis Rheum 46 (2002) 1735-1743
63. Choi J.H., Choi J.H., Kim D.Y., et al. Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model. Osteoarthritis Cartilage 6 (2002) 471-478
64. Chrubasik S., Pollak S., and Black A. Effectiveness of devil's claw for osteoarthritis. Rheumatology (Oxford) 41 (2002) 1332-1333 author reply 1333
65. Gagnier J.J., Chrubasik S., and Manheimer E. Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review. BMC Complement Altern Med 4 (2004) 13
66. Annual nutrition industry overview. Nutrition Business J 10 (2005) 6-7
67. Kelly G.S. The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease. Altern Med Rev 3 (1998) 27-39
68. Zhu X., Cai J., Yang J., et al. Determination of glucosamine in impure chitin samples by high-performance liquid chromatography. Carbohydr Res 340 (2005) 1732-1738
69. Tiraloche G., Girard C., Chouinard L., et al. Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis. Arthritis Rheum 52 (2005) 1118-1128
70. Karzel K., and Lee K.J. [Effect of hexosamine derivatives on mesenchymal metabolic processes of in vitro cultured fetal bone explants]. Z Rheumatol 41 (1982) 212-218
71. Setnikar I., Cereda R., Pacini M.A., et al. Antireactive properties of glucosamine sulfate. Arzneimittelforschung 41 (1991) 157-161
72. Michel B.A., Stucki G., Frey D., et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum 52 (2005) 779-786
73. Cibere J., Thorne A., Kopec J.A., et al. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers. J Rheumatol 32 (2005) 896-902
74. McAlindon T.E., LaValley M.P., Gulin J.P., et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 283 (2000) 1469-1475
75. Kim L.S., Axelrod L.J., Howard P., et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage 14 (2006) 286-294
76. Najm W.I., Reinsch S., Hoehler F., et al. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial [ISRCTN36233495]. BMC Musculoskelet Disord 5 (2004) 6
77. Harmand M.F., Vilamitjana J., Maloche E., et al. Effects of S-adenosylmethionine on human articular chondrocyte differentiation: an in vitro study. Am J Med 83 (1987) 48-54
78. Katzenstein P.L., Malemud C.J., Pathria M.N., et al. Early-onset primary osteoarthritis and mild chondrodysplasia: radiographic and pathologic studies with an analysis of cartilage proteoglycans. Arthritis Rheum 33 (1990) 674-684
79. Knowlton R.G., Katzenstein P.L., Moskowitz R.W., et al. Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasia. N Engl J Med 322 (1990) 526-530
80. Lohmann M. Untersuchungen zur Bedeutung von Gelatine als Proteinbestandteil. Inauguraldissertation; Agrarwissenschaftliche Fakultät, Universität Kiel; 1994.
81. Oesser S., Adam M., Babel W., et al. Oral administration of (14)C labeled gelatin hydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL). J Nutr 129 (1999) 1891-1895
82. Krug E. Zur unterstützenden Therapie bei Osteo- und Chondropathien. Zeitschrift für Erfahrungsheikunde 11 (1979) 930-938
83. Götz B. Gut genährter Knorpel knirscht nicht mehr. Arztl Prax 92 (1982) 3130-3134
84. Oberschelp U. Individuelle Arthrosetherapie ist möglich. Therapiewoche 44 (1985) 5094-5097
85. Adam M. Welche Wirkung haben Gelatinepräparate? Therapie der Osteoarthrose. Therapiewoche 41 (1991) 2456-2461
86. Moskowitz R.W. Role of collagen hydrolysate in bone and joint disease. Semin Arthritis Rheum 30 (2000) 87-99
87. Flechsenhar K., and Alf D. Ergebnisse einer Anwendungsbeobachtung zu Kollagen-Hydrolysat CH-Alpha. Orthopaedische Praxis 9 (2005) 486-494
88. Zuckley L, Angelopoulou K, Carpenter M, et al. Collagen hydrolysate improves joint function in adults with mild symptoms of osteoarthritis of the knee. Presented at 51st Annual American College of Sports Medicine. Indianapolis (IN), June 2-4, 2004.
89. Zuckley L., Angelopoulou K., Carpenter M.R., et al. Collagen hydrolysate improves joint function in adults with mild symptoms of osteoarthritis of the knee. Med Sci Sports Exerc 36 Suppl (2004) S153-S154